STOCK TITAN

Satellos Bioscience (MSLE) Stock Price, News & Analysis

MSLE NASDAQ

Company Description

Satellos Bioscience (NASDAQ: MSLE) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $203.7M, ranking #4,633 among all listed U.S. companies by market cap.

For FY2025, Satellos Bioscience reported net income of -$24.9M.

This page collects what Stock Titan holds for MSLE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$9.72
+2.80%
+0.27
Last updated: July 28, 2026 at 12:04
-
Performance 1 year
$203.7M

Satellos Bioscience (MSLE) stock last closed at $9.46. At a market capitalization of $203.7M, MSLE is classified as a micro-cap stock with approximately 20.8M shares outstanding.

See what a $1,000 investment in MSLE would be worth today

SEC Filings

Satellos Bioscience has filed 5 recent SEC filings, including 5 Form 6-K. The most recent filing was submitted on July 8, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all MSLE SEC filings →

Financial Highlights

net income was -$24.9M. The company generated -$23.6M in operating cash flow. With a current ratio of 7.77, the balance sheet reflects a strong liquidity position.

-$24.9M
Net Income (FY2025)
-$23.6M
Operating Cash Flow
Revenue (FY2025)

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Satellos Bioscience (MSLE) currently stands at 104.1 thousand shares, up 24.7% from the previous reporting period, representing 0.5% of the float. Since February 2026, short interest has increased by 1457.9%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for Satellos Bioscience (MSLE) currently stands at 1.0 days, down 42.5% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 3.0 days.

MSLE Company Profile & Sector Positioning

Satellos Bioscience (MSLE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ. In monthly performance, the stock ranks #28 among all tracked companies.

Frequently Asked Questions

What is the current stock price of Satellos Bioscience (MSLE)?

The current stock price of Satellos Bioscience (MSLE) is $9.455 as of July 27, 2026.

What is the market cap of Satellos Bioscience (MSLE)?

The market cap of Satellos Bioscience (MSLE) is approximately 203.7M. Learn more about what market capitalization means .

What is the net income of Satellos Bioscience (MSLE)?

The FY2025 net income of Satellos Bioscience (MSLE) is -$24.9M, from its most recent completed fiscal year.

What is the operating cash flow of Satellos Bioscience (MSLE)?

The operating cash flow of Satellos Bioscience (MSLE) is -$23.6M. Learn about cash flow.

What is the current ratio of Satellos Bioscience (MSLE)?

The current ratio of Satellos Bioscience (MSLE) is 7.77, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.